194 related articles for article (PubMed ID: 29408011)
1. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts.
Kuehl T; Lagares D
Matrix Biol; 2018 Aug; 68-69():94-105. PubMed ID: 29408011
[TBL] [Abstract][Full Text] [Related]
2. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.
Lagares D; Santos A; Grasberger PE; Liu F; Probst CK; Rahimi RA; Sakai N; Kuehl T; Ryan J; Bhola P; Montero J; Kapoor M; Baron M; Varelas X; Tschumperlin DJ; Letai A; Tager AM
Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237758
[TBL] [Abstract][Full Text] [Related]
3. Methods for Studying Myofibroblast Apoptotic Pathways.
Zhou Y; Lagares D
Methods Mol Biol; 2021; 2299():123-137. PubMed ID: 34028739
[TBL] [Abstract][Full Text] [Related]
4. p53 and Myofibroblast Apoptosis in Organ Fibrosis.
McElhinney K; Irnaten M; O'Brien C
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047710
[TBL] [Abstract][Full Text] [Related]
5. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.
Certo M; Del Gaizo Moore V; Nishino M; Wei G; Korsmeyer S; Armstrong SA; Letai A
Cancer Cell; 2006 May; 9(5):351-65. PubMed ID: 16697956
[TBL] [Abstract][Full Text] [Related]
7. Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model.
Johnson LA; Rodansky ES; Tran A; Collins SG; Eaton KA; Malamet B; Steiner CA; Huang S; Spence JR; Higgins PDR
Inflamm Bowel Dis; 2022 Feb; 28(2):161-175. PubMed ID: 34302470
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.
Dolivo DM; Larson SA; Dominko T
Cytokine Growth Factor Rev; 2017 Dec; 38():49-58. PubMed ID: 28967471
[TBL] [Abstract][Full Text] [Related]
9. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
Hinz B; Lagares D
Nat Rev Rheumatol; 2020 Jan; 16(1):11-31. PubMed ID: 31792399
[TBL] [Abstract][Full Text] [Related]
10. The novel small molecular BH3 mimetics SM3 and its regulation of cell apoptosis and autophagy.
Wang Y; Fan S; Li X; Xiaokaiti Y; Pan Y; Tie L; Li X
Biochem Biophys Res Commun; 2019 Sep; 517(1):15-22. PubMed ID: 31303271
[TBL] [Abstract][Full Text] [Related]
11. Matrix Stiffness: the Conductor of Organ Fibrosis.
Santos A; Lagares D
Curr Rheumatol Rep; 2018 Jan; 20(1):2. PubMed ID: 29349703
[TBL] [Abstract][Full Text] [Related]
12. Astaxanthin prevents pulmonary fibrosis by promoting myofibroblast apoptosis dependent on Drp1-mediated mitochondrial fission.
Zhang J; Xu P; Wang Y; Wang M; Li H; Lin S; Mao C; Wang B; Song X; Lv C
J Cell Mol Med; 2015 Sep; 19(9):2215-31. PubMed ID: 26119034
[TBL] [Abstract][Full Text] [Related]
13. Salinomycin and other polyether ionophores are a new class of antiscarring agent.
Woeller CF; O'Loughlin CW; Roztocil E; Feldon SE; Phipps RP
J Biol Chem; 2015 Feb; 290(6):3563-75. PubMed ID: 25538236
[TBL] [Abstract][Full Text] [Related]
14. Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogramming.
Merkt W; Zhou Y; Han H; Lagares D
Wound Repair Regen; 2021 Jul; 29(4):678-691. PubMed ID: 34117675
[TBL] [Abstract][Full Text] [Related]
15. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics.
Yu L; Liu S
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):553-60. PubMed ID: 24012660
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitors of Bcl-2 family proteins are able to induce tumor regression in a mouse model of pre-B-cell acute lymphocytic lymphoma.
Turner BC; Eves T; Refaeli Y
DNA Cell Biol; 2008 Mar; 27(3):133-42. PubMed ID: 18163880
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
19. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase inhibitors in the treatment of pulmonary fibrosis.
Garneau-Tsodikova S; Thannickal VJ
Curr Med Chem; 2008; 15(25):2632-40. PubMed ID: 18855683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
